NAT
|
N650383-50mg
|
≥99% |
831243-31-3 |
50mg
|
¥ 5500.9
|
期货,请咨询 |
阿拉丁 |
NAT
|
N650383-25mg
|
≥99% |
831243-31-3 |
25mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
NAT
|
N650383-10mg
|
≥99% |
831243-31-3 |
10mg
|
¥ 1600.9
|
期货,请咨询 |
阿拉丁 |
NAT
|
N650383-100mg
|
≥99% |
831243-31-3 |
100mg
|
¥ 8500.9
|
期货,请咨询 |
阿拉丁 |
N-Desmethyl Bedaquiline-d6
|
N650342-1mg
|
≥96% |
2271264-26-5 |
1mg
|
¥ 7200.9
|
期货,请咨询 |
阿拉丁 |
NSC745885
|
N650304-5mg
|
≥98% |
4219-52-7 |
5mg
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |
NSC745885
|
N650304-50mg
|
≥98% |
4219-52-7 |
50mg
|
¥ 13000.9
|
期货,请咨询 |
阿拉丁 |
NSC745885
|
N650304-10mg
|
≥98% |
4219-52-7 |
10mg
|
¥ 4500.9
|
期货,请咨询 |
阿拉丁 |
NSC745885
|
N650304-100mg
|
≥98% |
4219-52-7 |
100mg
|
¥ 18000.9
|
期货,请咨询 |
阿拉丁 |
NDB
|
N650302-5mg
|
≥98% |
1660153-08-1 |
5mg
|
¥ 1600.9
|
期货,请咨询 |
阿拉丁 |
NDB
|
N650302-50mg
|
≥98% |
1660153-08-1 |
50mg
|
¥ 8190.9
|
期货,请咨询 |
阿拉丁 |
NDB
|
N650302-25mg
|
≥98% |
1660153-08-1 |
25mg
|
¥ 5120.9
|
期货,请咨询 |
阿拉丁 |
NDB
|
N650302-10mg
|
≥98% |
1660153-08-1 |
10mg
|
¥ 2560.9
|
期货,请咨询 |
阿拉丁 |
NDB
|
N650302-100mg
|
≥98% |
1660153-08-1 |
100mg
|
¥ 13100.9
|
期货,请咨询 |
阿拉丁 |
1-Naphthyl PP1 hydrochloride
|
N650270-5mg
|
≥99% |
956025-47-1 |
5mg
|
¥ 800.9
|
期货,请咨询 |
阿拉丁 |
1-Naphthyl PP1 hydrochloride
|
N650270-50mg
|
≥99% |
956025-47-1 |
50mg
|
¥ 4100.9
|
期货,请咨询 |
阿拉丁 |
1-Naphthyl PP1 hydrochloride
|
N650270-25mg
|
≥99% |
956025-47-1 |
25mg
|
¥ 2560.9
|
期货,请咨询 |
阿拉丁 |
1-Naphthyl PP1 hydrochloride
|
N650270-10mg
|
≥99% |
956025-47-1 |
10mg
|
¥ 1280.9
|
期货,请咨询 |
阿拉丁 |
1-Naphthyl PP1 hydrochloride
|
N650270-100mg
|
≥99% |
956025-47-1 |
100mg
|
¥ 6600.9
|
期货,请咨询 |
阿拉丁 |
NF-κB-IN-1
|
N650195-5mg
|
≥99% |
1227098-15-8 |
5mg
|
¥ 4800.9
|
期货,请咨询 |
阿拉丁 |
NF-κB-IN-1
|
N650195-1mg
|
≥99% |
1227098-15-8 |
1mg
|
¥ 1828.9
|
期货,请咨询 |
阿拉丁 |
NF-κB-IN-1
|
N650195-10mg
|
≥99% |
1227098-15-8 |
10mg
|
¥ 8000.9
|
期货,请咨询 |
阿拉丁 |
Nilofabicin
|
N650181-50mg
|
Moligand™, ≥99% |
934628-27-0 |
50mg
|
¥ 2400.9
|
期货,请咨询 |
阿拉丁 |
Nilofabicin
|
N650181-100mg
|
Moligand™, ≥99% |
934628-27-0 |
100mg
|
¥ 4000.9
|
期货,请咨询 |
阿拉丁 |